JP2015522562A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015522562A5 JP2015522562A5 JP2015516391A JP2015516391A JP2015522562A5 JP 2015522562 A5 JP2015522562 A5 JP 2015522562A5 JP 2015516391 A JP2015516391 A JP 2015516391A JP 2015516391 A JP2015516391 A JP 2015516391A JP 2015522562 A5 JP2015522562 A5 JP 2015522562A5
- Authority
- JP
- Japan
- Prior art keywords
- antibody
- pharmaceutical composition
- fragment
- composition according
- seq
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261658569P | 2012-06-12 | 2012-06-12 | |
| US61/658,569 | 2012-06-12 | ||
| US201361809604P | 2013-04-08 | 2013-04-08 | |
| US61/809,604 | 2013-04-08 | ||
| PCT/CA2013/000569 WO2013185215A1 (en) | 2012-06-12 | 2013-06-11 | Antibodies and conjugates that target misfolded prion protein |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2015522562A JP2015522562A (ja) | 2015-08-06 |
| JP2015522562A5 true JP2015522562A5 (https=) | 2016-08-04 |
| JP6430373B2 JP6430373B2 (ja) | 2018-11-28 |
Family
ID=49757359
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015516391A Expired - Fee Related JP6430373B2 (ja) | 2012-06-12 | 2013-06-11 | ミスフォールドプリオンタンパク質を標的とする抗体および複合体 |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US9296819B2 (https=) |
| JP (1) | JP6430373B2 (https=) |
| CA (1) | CA2877505C (https=) |
| WO (1) | WO2013185215A1 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5823663B2 (ja) | 2006-03-03 | 2015-11-25 | プロミス ニューロサイエンシズ インコーポレイテッド | ミスフォールドsod1媒介疾患を処置および検出するための方法および組成物 |
| CA2908475C (en) * | 2013-04-08 | 2020-09-08 | Helix Biopharma Corp. | Use of antibody-urease conjugates for diagnostic and therapeutic purposes |
| WO2014186878A1 (en) | 2013-05-24 | 2014-11-27 | Cashman Neil R | Cell senescence markers as diagnostic and therapeutic targets |
| WO2016094715A2 (en) | 2014-12-10 | 2016-06-16 | Berkeley Lights, Inc. | Movement and selection of micro-objects in a microfluidic apparatus |
| PL238187B1 (pl) * | 2015-01-23 | 2021-07-19 | Helix Biopharma Corp | Koniugaty przeciwciało-ureaza dla celów terapeutycznych |
| AU2016323968B2 (en) | 2015-09-17 | 2023-07-06 | Immunogen, Inc. | Therapeutic combinations comprising anti-FOLR1 immunoconjugates |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1194164B8 (en) * | 1999-06-23 | 2007-03-21 | IDEXX Laboratories Inc | Prion protein peptides and uses thereof |
| NZ515982A (en) * | 2000-12-08 | 2003-09-26 | Fujirebio Kk | Method and monoclonal antibodies for differentiation between abnormal and normal prions |
| WO2005019828A1 (en) * | 2003-08-20 | 2005-03-03 | Amorfix Life Sciences Ltd. | Epitope protection assay and method for detecting protein conformations |
| AU2009301580B2 (en) | 2008-10-06 | 2015-11-26 | The University Of British Columbia | Methods and systems for predicting misfolded protein epitopes |
-
2013
- 2013-06-11 US US14/407,724 patent/US9296819B2/en not_active Expired - Fee Related
- 2013-06-11 JP JP2015516391A patent/JP6430373B2/ja not_active Expired - Fee Related
- 2013-06-11 WO PCT/CA2013/000569 patent/WO2013185215A1/en not_active Ceased
- 2013-06-11 CA CA2877505A patent/CA2877505C/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI3332006T3 (fi) | Uusia anti-PD-L1-vasta-aineita | |
| JP2015522562A5 (https=) | ||
| MY190771A (en) | Anti-pd-l1 antibodies and uses thereof | |
| JP2014205674A5 (https=) | ||
| PH12020551173A1 (en) | Anti-pd-l1 antibodies and uses thereof | |
| JP2017048240A5 (https=) | ||
| NZ625403A (en) | Composition and method for diagnosis and treatment of diseases associated with neurite degeneration | |
| JP2016537383A5 (https=) | ||
| JP2015530971A5 (https=) | ||
| BR112013008765B8 (pt) | Anticorpos monoclonais anti-tau humano isolados ou um fragmento de ligação à tau dos mesmos, métodos de preparação dos mesmos, polinucleotídeo ou polinucleotídeos, vetor ou vetores, composição, método in vitro de diagnóstico ou monitoramento da progressão de uma tauopatia neurodegenerativa em um indivíduo humano, método in vitro para diagnosticar uma tauopatia neurodegenerativa em um indivíduo humano, e kit útil para o diagnóstico de uma tauopatia neurodegenerativa | |
| IL273196B2 (en) | Claudin6 antibodies and methods of treating cancer | |
| JP2013506428A5 (https=) | ||
| JP2017176174A5 (https=) | ||
| JP2017535257A5 (https=) | ||
| JP2016511254A5 (https=) | ||
| JP2015535828A5 (https=) | ||
| JP2015514110A5 (https=) | ||
| PH12014500089A1 (en) | Antibodies that bind to ox40 and their uses | |
| JP2014533239A5 (https=) | ||
| JP2013500940A5 (https=) | ||
| AR052959A1 (es) | Anticuerpos anti- ccr5 y usos de los mismos | |
| JP2015503909A5 (https=) | ||
| JP2013519364A5 (https=) | ||
| JP2017508475A5 (https=) | ||
| JP2015531768A5 (https=) |